95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-23.42%
Negative revenue growth while FSM stands at 12.04%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-18.86%
Negative gross profit growth while FSM is at 31.19%. Joel Greenblatt would examine cost competitiveness or demand decline.
-23.52%
Negative EBIT growth while FSM is at 10.11%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-23.52%
Negative operating income growth while FSM is at 10.11%. Joel Greenblatt would press for urgent turnaround measures.
463.45%
Net income growth above 1.5x FSM's 167.85%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
460.00%
EPS growth above 1.5x FSM's 132.56%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
460.00%
Diluted EPS growth above 1.5x FSM's 132.56%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while FSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-31.36%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-31.00%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
124.38%
10Y revenue/share CAGR under 50% of FSM's 440.99%. Michael Burry would suspect a lasting competitive disadvantage.
-20.60%
Negative 5Y CAGR while FSM stands at 28.18%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-3.10%
Negative 3Y CAGR while FSM stands at 16.77%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.65%
10Y OCF/share CAGR at 75-90% of FSM's 132.72%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
-41.38%
Negative 5Y OCF/share CAGR while FSM is at 71.12%. Joel Greenblatt would question the firm’s operational model or cost structure.
-15.46%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
22.82%
Below 50% of FSM's 454.43%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-66.69%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-37.90%
Negative 3Y CAGR while FSM is 119.40%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
256.57%
10Y equity/share CAGR 1.25-1.5x FSM's 203.27%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
44.22%
5Y equity/share CAGR at 50-75% of FSM's 68.89%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
17.38%
Below 50% of FSM's 64.70%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
43.26%
AR growth well above FSM's 26.69%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-1.10%
Negative asset growth while FSM invests at 13.39%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.73%
Under 50% of FSM's 10.09%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-10.81%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
114.57%
SG&A growth well above FSM's 192.88%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.